| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), GNPX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 45.7K | - | - | |
| Other | 28.9K | - | - | |
| Dir | 9.2K | - | - | |
| Dir | 9.2K | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | Longnecker Brent M | Director | Sell | 18 | $1.23 | $22.14 | -100% | -53.7% | - | |
| Apr 21, 2023 | Varner John Rodney | Chairman, President And CEO | Buy | 19,000 | $1.06 | $20,045.00 | +1,056% | -19.2% | -95.0% | |
| Apr 21, 2023 | Vaczy Catherine M | EVP GC Chief Strategy Officer | Buy | 20,000 | $1.07 | $21,478.00 | +8.2% | -19.2% | -95.0% | |
| Apr 5, 2021 | Longnecker Brent M | Director | Buy | 15,000 | $4.15 | $62,250.00 | New | -23.1% | -48.8% | |
| Sep 5, 2019 | Varner John Rodney | Chief Executive Officer | Buy | 1,800 | $0.89 | $1,594.62 | New | - | - | |
| Jul 30, 2018 | Pham Julien L | President &COO | Buy | 500 | $3.40 | $1,700.00 | New | - | - | |
| Mar 29, 2018 | Nance Christy M. | 10% Owner | Buy | 50,000 | $5.00 | $250,000.00 | New | - | - | |
| Mar 29, 2018 | Roth Jack A | 10% Owner | Buy | 40,000 | $5.00 | $200,000.00 | +3.1% | - | - | |
| Mar 29, 2018 | Varner John Rodney | Chief Executive Officer | Buy | 10,000 | $5.00 | $50,000.00 | +1.9% | - | - |